Wells Fargo Starts Amphastar Pharmaceuticals (AMPH) at Outperform
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $20.09 -2.14%
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Wells Fargo initiated coverage on Amphastar Pharmaceuticals (NASDAQ: AMPH) with an Outperform rating.
For an analyst ratings summary and ratings history on Amphastar Pharmaceuticals click here. For more ratings news on Amphastar Pharmaceuticals click here.
Shares of Amphastar Pharmaceuticals closed at $11.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
- BofA Securities Resumes Williams-Sonoma (WSM) at Buy
- Wolfe Research Starts SpaceX (SPCX) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
